Which country's health authority has authorised AstraZeneca’s Evusheld for pre-exposure prevention of COVID-19?
Explanation:
The United States health authorities on December 8, 2021, authorized the use of synthetic antibodies that have been developed by AstraZeneca for preventing Coronavirus infections in individuals who react badly to the COVID-19 vaccines.